n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, June 21st, 2017

The QualityStocks
Daily Stock List

graphic
graphic

Gripevine, Inc. (GRPV)

We are reporting on Gripevine, Inc. (GRPV) today, here at the QualityStocks Daily Newsletter.

Gripevine, Inc. is an enterprise focusing on leading the revolution of social customer service. The Company is a proprietary complaint-resolution platform for the facilitation and management of social customer service by way of centralized communication, rating, as well as review tools. It has a highly scalable and sustainable growth model. Gripevine has its corporate head office in New York, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Gripevine has a platform where, as the Company states, all sides can be heard. It has a user-friendly social CRM (Customer Relationship Management) platform for users to engage on. The emphasis is on turning negative experiences into positive outcomes. The focus is amicable or harmonious social customer service solutions for every business sector.

In essence, the tools that Gripevine offers to business and consumers incentivize positive and agreeable outcomes and reward reliable consumers and responsive businesses. The Company provides a thriving social engine for consumers as well as unparalleled back end tools for businesses.
Gripevine is the next development in social customers relations. In addition, the Company is the central hub of activity where business and consumers can be heard regarding their particular concerns.

Gripevine develops, owns, and also operates social customer relations applications on desktop and mobile computing platforms. The Company has unique patents. These patents propel a flourishing community and provide businesses first-rate control over their social public image.

Gripevine’s corporate mission is to establish itself as a worldwide leader in social consumer resolution and relationship management. It works to accomplish this through providing businesses strong tools to manage their social presence while providing consumers with tangible resolution results and a social engine.

High profiles companies and localized SME’s (small and medium-sized enterprises) use Gripevine. The Company expedites the resolution process between consumers and businesses. Fundamentally, Gripevine creates a fair space for business and consumers to interact.

Gripevine, Inc. (GRPV), closed Wednesday's trading session at $0.30, up 42.86%, on 27,636 volume with 11 trades. The average volume for the last 60 days is 35,380 and the stock's 52-week low/high is $0.205/$1.60.

Plandaí Biotechnology, Inc. (PLPL)

Stockgoodies, CFN Media Group, PennyStockLocks, ResearchOTC, StockRockandRoll, WallstreetSurfers, Cannabis Financial Network News, SmallCapVoice, MyBestStockAlerts, Jet-Life Penny Stocks, Otcstockexchange, PennyStocks24, Whisper from Wall Street, and Stock Market Media Group reported earlier on Plandaí Biotechnology, Inc. (PLPL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Plandaí Biotechnology, Inc. is the producer of the highly bioavailable Phytofare® Catechin Complex. The Company and its subsidiaries develop highly phyto-available™ extracts. Targeted industries for its products include beverage, cosmeceutical, wellness, nutriceutical, anti-aging, and pharmaceutical. Plandaí Biotechnology has its headquarters in London, England. It has an international presence with representatives in the U.S. and South Africa. The Company lists on the OTC Markets Group’s OTCQB.

Plandaí Biotechnology’s main holdings comprise land, farms, and infrastructure. These total greater than 7500 acres, in the province of Mpumalanga, South Africa. The Company’s project is the first botanical extraction business in South Africa addressing the issues of unprofitable tea estates through making them viable via the harvesting of fresh green tea leaf for the exclusive purpose of extracting a bioavailable green tea gallate catechin extract.

Plandaí’s extracts include, but are not limited to, gallate catechins from green tea, (catechin gallate (CG), epigallocatechin gallate (EGCG), gallocatechin gallate (GCG), and epicatechin gallate (ECG)); carotenoids (lycopene) from tomatoes, and also citrus bioflavonoids and limonoids. In addition, the Company’s gallate catechin extract will be the active ingredient in formulated products supporting weight loss, antiaging, the lowering of blood cholesterol, the regulation of high blood pressure, and controlling diabetes I and II.

The Company farms an entire fruit basket of produce that it utilizes in its creation of highly bioavailable extracts. These range from citrus to avocado pears to more than 2000 acres of tea. Plandaí’s farming team has more than 100 years of experience in managing farms in Southern Africa.

Last month, Plandaí Biotechnology announced that its green tea catechin-based Phytofare® will be the active ingredient in a human clinical trial investigating the effectiveness of using Phytofare® to regulate blood glucose levels in Type II diabetics. The trial is sponsored by Plandaí's licensee, ProText Mobility, Inc. The trial will be conducted by the Centre International de Developpment Pharmaceutique (CIDP) in the nation of Mauritius. Mauritius was chosen as the site for the human clinical trial because an estimated 25 percent of the population suffers from Type II Diabetes.

Additionally, in May, Plandaí Biotechnology announced that it successfully shipped an order for 1.2 million Origine 8™ capsules to Coyne Healthcare. Origine 8™ consists of all eight Phytofare® catechins that are subsequently entrapped in nutrient-protective liposomes. This product is undergoing launch in the United Kingdom (UK) and the U.S. Coyne Healthcare has forecasted sales of 10.6 million Origine 8™ capsules for 2017 with sales rising to 24 million for 2018. Coyne Healthcare is a nutraceutical and food supplement enterprise headquartered in South Africa.

Plandaí Biotechnology, Inc. (PLPL), closed Wednesday's trading session at $0.018, up 9.09%, on 1,767,180 volume with 24 trades. The average volume for the last 60 days is 932,790 and the stock's 52-week low/high is $0.0101/$0.0624.

Diamante Minerals, Inc. (DIMN)

MarketWatch, Bloomberg, MicroCapDaily, Barchart, and OTC Markets reported on Diamante Minerals, Inc. (DIMN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Diamante Minerals, Inc. is an exploration stage natural resources company concentrating on the diamond sector. It works to identify, explore, as well as develop premier diamond bearing properties globally. It formerly went by the name Oconn Industries Corp. It changed its corporate name to Diamante Minerals, Inc. in April of 2014. Diamante Minerals has its head office in Kelowna, British Columbia.

Diamante is focusing on acquiring its initial 20 percent interest in the Batovi Diamond Project and also in developing the Project. The Batovi Diamond Project was optioned by Diamante Minerals and it is 220 kilometers north of the town of Paranatinga in Mato Grosso, Brazil. The landlocked province of Mato Grosso is in central Brazil.

Mato Grosso has been the emphasis of much of Diamante Minerals’ exploration work in the nation. Surveys in this region have shown the presence of indicator minerals. These include garnets and chrome spinels. This represents a clear sign that kimberlite is a possibility.

The Batovi Diamond Project represents a first-rate opportunity for the discovery of diamond bearing kimberlite intrusives. In addition, the Project has potential for the development of alluvial diamond production from diamondiferous gravels associated with the Rio Batovi drainage basin and its tributaries.

Furthermore, Diamante has a gold stream agreement for the Molejon Gold Mine in the Donoso District, Colon Province of Panama. The Company negotiated a royalty of 12.5 percent on 1,000 ounces of gold produced each month for 12 months.  In the event monthly production is greater than 1,000 ounces, Diamante Minerals is to receive an additional 5 percent royalty.

Diamante hired a legal firm in Panama to pursue the acquisition by Diamante Minerals of the Molejon Mine. Representatives of the firm were in discussions with a committee formed by the Panamanian government to supervise the transfer of interests of the Molejon Mine. The Company said earlier this year that it is optimistic that its efforts will be successful and that it will be appointed the owner and operator of the Molejon Mine. Nonetheless, there are no assurances that such an appointment will be made.

Production at the Molejon Mine began in 2009, with an initial throughput of 2,200 tons per day (tpd).  In September of 2011, the mine had proven and probable mineral reserves of 643,266 ounces of gold and certain additional mineralized material. In 2012, the plant underwent expansion to 3,500 tpd, resulting in a yearly gold equivalent production of 69,000 ounces in 2012 and again in 2013 before closing late in the year.

In January of this year, Diamante Minerals announced that it amended its Mineracao Batovi Agreement in Brazil. Moreover, it announced that it acquired a 2.4 percent Interest in the Batovi Project. With the amended agreement, the joint venture (JV) to develop the Mineracao Batovi project will be effected by way of holdings in Mineracao Batovi Ltda. the Brazilian company now holding the Mato Grosso claims as opposed to through a newly formed JV company as originally contemplated.

Additionally, it was agreed that the deadline to fund the initial US$1,000,000 in expenses is June 30, 2017. This funding will result in Diamante Minerals obtaining a 17.6 percent equity interest in Mineracao in circumstances where the full US$1,000,000 is funded (or a pro rata portion thereof in circumstances where only a portion of the US$1,000,000 is funded by the deadline).

Diamante Minerals, Inc. (DIMN), closed Wednesday's trading session at $0.09, down 8.16%, on 156,720 volume with 4 trades. The average volume for the last 60 days is 23,073 and the stock's 52-week low/high is $0.0274/$0.51.

Boston Therapeutics, Inc. (BTHE)

Wall Street Mover, RedChip, TaglichBrothers, Stock News Now, TopPennyStockMovers, SmallCapVoice, PennyStocks24, MissionIR, Tiny Gems, FeedBlitz, and Information Solutions Group reported previously on Boston Therapeutics, Inc. (BTHE), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Boston Therapeutics, Inc. is a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases. The Company’s product pipeline centers on developing and commercializing therapeutic molecules that address diabetes and inflammatory diseases. Additionally, it developed and markets SUGARDOWN®. This is a non-systemic, complex carbohydrate-based dietary food supplement. The design of SUGARDOWN® is to support healthy blood glucose. Boston Therapeutics is based in Lawrence, Massachusetts.

Boston Therapeutics’ product pipeline includes BTI-320. This is a non-systemic, non-toxic, chewable complex carbohydrate-based compound. The design of it is to reduce post-meal glucose elevation.

BTI-320 is a proprietary polysaccharide. BTI-320 works in the gastrointestinal tract to block the action of carbohydrate-hydrolyzing enzymes, which break down complex carbohydrates into simple sugars, lessening the availability of glucose for absorption into the bloodstream.

The Company entered a clinical trial agreement with Joslin Diabetes Center to be the lead clinic in a Phase II study of BTI-320. Also, its product pipeline includes IPOXYN™. This is an injectable anti-necrosis drug. The design of it at first is to treat lower limb ischemia associated with diabetes.

In addition, the Company’s product pipeline includes OXYFEX™. This product can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events. OXYFEX™ is Boston Therapeutics’ veterinary facsimile to IPOXYN™.

In 2015, Boston Therapeutics announced that its affiliate, Advance Pharmaceutical, initiated the SUGARDOWN® clinical trial in Hong Kong. Advance Pharmaceutical is evaluating the effect of SUGARDOWN® on Post-Prandial Hyperglycemia in Chinese subjects with Pre-Diabetes. The lead clinical site is the Department of Medicine, The Chinese University of Hong Kong (CUHK), Prince of Wales Hospital.

Advance Pharmaceutical is conducting this clinical trial at CUHK to evaluate BTI-320 in subjects who are pre-diabetic. The interim clinical analysis in the proof of concept trial demonstrate up to 77 percent reduction in Glucose and up to 27 percent in Fructose.

This past April, Boston Therapeutics and Advance Pharmaceutical announced the fully financed new trial plans to support the safety and efficacy of BTI-320, beginning with a randomized, placebo-controlled, double-blinded, multi-center, global study on type 2 diabetic (T2D) patients. The study will start as soon as drug supply is processed and will ultimately include 300 T2D patients presently on anti-diabetic regimen. Recruitment will begin at the Joslin Diabetes Center, Boston, Massachusetts. It will be joined by its former trial center from the Chinese University of Hong Kong (CUHK) that has also been confirmed. The plans anticipate up to 10 additional institutions from the U.S. and greater China.

This week, Mr. Carl Rausch, Boston Therapeutics’ Chief Executive Officer, and its Asian partner Advance Pharmaceutical had data presented from the proof of concept trial (Protocol Code: SG01) conducted by CUHK. Presentation was made this June 2017 in a presentation at the ADA’s 77th scientific sessions (Abstract: Hyperglycemia in High-Risk Chinese Subjects with Prediabetes) in San Diego, California (June 9-13). A copy of the abstract is printed in the Scientific Sessions Abstract Book (June 2017), supplement to the journal Diabetes.

Overall, BTI-320 was well tolerated. These positive findings suggest that BTI-320 works by predominately suppressing postprandial glucose excursion, slowing down the rate of glucose excursion, and decreasing the absolute amount absorbed, thus preventing hyperglycemia without the risk of hypoglycemia.

Boston Therapeutics, Inc. (BTHE), closed Wednesday's trading session at $0.04812, up 20.30%, on 7,000 volume with 2 trades. The average volume for the last 60 days is 18,331 and the stock's 52-week low/high is $0.04/$0.17.

Two Rivers Water & Farming Company (TURV)

Jet-Life Penny Stocks, Stock News Now, Cannabis Financial Network News, SmallCapVoice, TopPennyStockMovers, IRGnews Alert, and Stock Guru reported on Two Rivers Water & Farming Company (TURV), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is building a new water model for the arid regions of the southwestern United Sates. The Company assembles its water assets through acquiring irrigated farmland with senior water rights because 85 percent of water rights in the arid southwest are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland by continually developing operations that produce higher revenues and better profit margins. Two Rivers Water & Farming is headquartered in Denver, Colorado. GrowCo, Inc. is an indirect subsidiary of the Company.

Two Rivers’ current farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County, Colorado. The Company provides greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. Additionally, Two Rivers develops Metropolitan Districts to serve underserved communities in rural regions in which Two Rivers' farmland and water rights are situated.

Two Rivers’ produce sells to national accounts by way of its wholly-owned subsidiary Dionisio Farms & Produce. Regarding Water, Two Rivers owns a portfolio of water rights in the Arkansas River Basin in Colorado, obtained in connection with its purchases of irrigated farmland.

The Company’s majority-owned subsidiary, GrowCo, was formed in May of 2014 to construct greenhouses and processing facilities for lease to licensed marijuana growers in Colorado. GrowCo, through its subsidiaries, combines proprietary greenhouse technology with the water, land, and capital to build state-of-the-art greenhouse facilities for licensed marijuana growers. GrowCo centers on the building of cannabis greenhouses and providing financing and administrative services to the tenants of the greenhouses.

GrowCo announced in 2016 that a new tenant, a sublease of its existing tenant, was approved on November 28, 2016 by the Pueblo County Liquor and Marijuana Licensing Board to immediately commence growing marijuana in GrowCo's first greenhouse located in Pueblo County, Colorado.

In February of this year, Two Rivers announced that its subsidiary GrowCo, via GrowCo Partners 1, LLC (GCP1), leased space to a second tenant to grow marijuana in GrowCo's greenhouses located in Pueblo County. With the lease, the Company’s first greenhouse is now completely leased with revenue accruing.

In March, the Company announced it created a separate company to concentrate on its existing and future investments in water. The new subsidiary is Water Redevelopment Company, which is a Delaware corporation. Water Redevelopment completed its first initial seed capital of $257,000. After this first initial round, Two Rivers Water & Farming Company owns 99 percent of Water Redevelopment Company.

Two Rivers Water & Farming Company (TURV), closed Wednesday's trading session at $0.300396, down 6.13%, on 50,741 volume with 23 trades. The average volume for the last 60 days is 62,266 and the stock's 52-week low/high is $0.12/$1.19.

graphic

The QualityStocks
Company Corner

graphic
graphic

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.1051, even with yesterday's close. The stock’s average daily volume over the past 60 days is 13,865 and its 52-week low/high is $0.0001/$0.75.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp Announces Engagement of Atlanta-Based Broker Dealer Carter, Terry & Company

Algae Dynamics Corp Announces Memorandum Of Understanding With Bonify for Supply of Cannabis, Oil Extraction and Sales

Algae Dynamics Corp Announces Joint Venture With ARA - Avanti Rx Analytics Inc. to Formulate, Manufacture and Sell Products Utilizing Algae, Hemp & Cannabis Oils

BlastGard International Inc. (BLGA)

The QualityStocks Daily Newsletter would like to spotlight BlastGard International Inc. (BLGA). Today, BlastGard International Inc. closed trading at $0.0225, even for the day, on 205,250 volume with 9 trades. The stock’s average daily volume over the past 60 days is 115,265 and its 52-week low/high is $0.004/$0.03.

BlastGard International Inc. manufacturer and distributor of protective products for military and law enforcement personnel, and developer of the patented BlastWrap® technology which effectively mitigates blast effects and suppresses post-blast fires, announces that it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

BlastGard International Inc. (BLGA) is a manufacturer and distributor of protective products for military and law enforcement personnel. The Corporation operates under two segments, BlastGard Defense Group and Highcom Security.

Blastguard is a blast mitigation specialist with proprietary material proven to effectively mitigate blasts and suppress fires resulting from explosions. The company's patented BlastWrap® technology acts as a "virtual tent" to effectively mitigate blast effects and suppress post-blast fires. This unique technology works by triggering physical and chemical processes to dissipate blast energy, thereby reducing the aftermath of acoustic and shock waves, peak overpressure, reflected peak overpressure, impulse and afterburn. The remaining, significantly reduced energy is transmitted at a slower, more sustainable level. Notably, BlastWrap does not dispense chemical extinguishants; uses neither alarms, sensors, nor an activation system; and is nontoxic and ecologically friendly.

Similarly, the company's BlastGard MTR trash receptacles dramatically reduce lethal threats posed by the detonation of an improvised explosive device (IED). Equipped with Triple Wall Technology, BlastGard MTR mitigates primary fragments, secondary fragments, mechanical effects (shock/blast pressure) and thermal effects (contact and radiation burn) from the fireball, after-burn and resultant post-blast fires.

BlastGard's primary market focus lies on providing blast effects mitigation solutions for customers operating in the commercial sector, military, law enforcement and government agencies. With a vision of being recognized as the leading provider of environmentally responsible solutions to protect lives and structures from the hazards associated with fire and explosions, the company is capable of addressing a wide array of industry applications spanning from fire suppression for naval vessels and merchant ships to protection of buildings against vehicle bombs.

This vision is supported by the ban of Halon extinguishing agents, as outlined in the Montreal protocol, which effectively establishes BlastWrap® as the only blast and fire suppression means available for most applications, including adaptation for underwater use.

The company's position at the head of the blast suppression market has helped BlastGard attain a number of government awards, including designation of its BlastWrap® product as a Qualified Anti-Terrorism Technology and placement on the "Approved Products List for Homeland Security." This designation was extended in early 2017, meaning that BlastWrap® is approved for use by the Department of Homeland Security under the SAFETY Act until November 2021.

HighCom Security, develops, tests, manufactures and distributes body armor and personal protective equipment, including more than two dozen NIJ (National Institute of Justice) compliant hard and soft armor products. Highcom Security has a 20-year history of producing quality armor with no operational failures and no recalls of its American made products.

Highcom Security was founded in 1997 and has produced close to 1 million pieces of armor for the Global community. The company is ISO 9001:2008 certified and the first company in the world to be BA 9000:2012 certified compliant.

For the past decade, Highcom Security has also been able to offer some of the largest armor manufacturers with private label/OEM hard armor solutions for end use by military and law enforcement agencies globally, a market reach obtained because of the company's reputation for innovative technology, exceptional customer service and superior quality performance. Disclaimer

BlastGard International Inc. Blog

BlastGard International Inc. News:

BlastGard International, Inc. (BLGA) Engages NetworkNewsWire for Corporate Communications Solutions

BlastGard International Inc. (BLGA) is “One to Watch”

BlastGard International Addresses Company's Trading Activity

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.42, even for the day, on 77,572 volume with 25 trades. The stock’s average daily volume over the past 60 days is 106,341 and its 52-week low/high is $0.05/$2.09.

ORHub, Inc. today announces a $0.50 exercise price for all the Company's Series B & D Warrants. As recently announced (http://nnw.fm/D2kfb), ORHub in July 2017 will launch its second service line, Module 2 for hip and knee surgical procedures. With over 100 million surgeries performed in the U.S. every year and growing, this new hip and knee module significantly expands the addressable market for the Company's dynamic analytics capabilities and Surgical Resource Management platform.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub (ORHB) Sets Exercise Price for its Series B and D Warrants

ORHub, Inc. Expands its Addressable Market with Launch of Transformative Hip and Knee Module

ORHub (ORHB) Enhances Leading Data Analytics Platform with Integration of Sterilization Process Module

ProBility Media Corp. (PBYA)

The QualityStocks Daily Newsletter would like to spotlight ProBility Media Corp. (PBYA). Today, ProBility Media Corp. closed trading at $0.448, up 14.87%, on 10,916 volume, with 5 trades. The stock’s average daily volume over the past 60 days is 3,529, and its 52-week low/high is $0.1205/$1.16.

ProBility Media Corp. (PBYA) based in Houston, TX, is an EdTech Company that is building the first full service training and career advancement brand for the skilled trades. Through both acquisitions and organic growth, ProBility is executing a disruptive strategy of defragmenting the market place of disparate companies servicing fifteen vertical categories in over sixty skilled trades. ProBility has positioned itself as a key industrial training resource for individuals, small- and medium-size businesses as well as enterprise customers offering consistent high-quality training services and materials for education, testing, and career advancement.

Through its Electrical Training Division, the company has become the biggest wholesaler of electrical codes and test preparation materials in the U.S., while its Construction Training Division is one of the largest certification providers in the country, with programs in 22 states, and continuing to grow. The company serves corporate accounts and government buyers, and also offers advisory services for companies of all sizes.

Companies currently under the ProBility Media conglomerate include:

  • Brown Technical Media Corp. – An online web business with multiple micro web sites featuring training materials and codes and standards sought by engineers, construction workers, scientists and other tradesmen in a wide variety of fields.
  • Brown Technical Publications – A proprietary publishing business generating copyrighted training materials for engineers, construction workers, scientists and other tradesman in a wide variety of fields.
  • 1ExamPrep – E-Learning, education and exam preparation for contractors via the cheapest, fastest and most effective exam prep school in the industry instituting our 4-point proven learning system.
  • National Electrical Wholesale Providers – In the business of distributing wholesale industrial, commercial and residential training materials including HVAC, plumbing and electrical.

ProBility's technology platform features virtual reality training for the crane business to be expanded into other industries, online subscription services for enterprise level companies, and recurring revenue streams. In addition, the company is already beginning to explore international expansion options, supported by the fact that other countries have adopted U.S. based codes, and have used U.S. training services.

The company's acquisition strategy targets operations that service engineering firms, electrical contractors, fabricators, plumbing contractors, pipe fitters, riggers, QC firms, and additional vocational industries. Disclaimer

ProBility Media Corp. Company Blog

ProBility Media Corp. News:

ProBility Media Corp. Reports Fourth Consecutive Quarter of Revenue Growth

ProBility Media Corp. Signs Binding Letter of Intent to Acquire W Marketing

ProBility Media Corp. Expands Distribution with New 2017 Electrician Exam Preparation Series

National Waste Management Holdings, Inc. (NWMH)

The QualityStocks Daily Newsletter would like to spotlight National Waste Management Holdings, Inc. (NWMH). Today, National Waste Management Holdings, Inc. closed trading at $0.10, up 20.48%, on 3,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 18,606, and its 52-week low/high is $0.06/$0.145.

National Waste Management Holdings, Inc. (NWMH) is a solid waste management company offering comprehensive solutions for full waste diversion along Florida's west coast and in upstate New York. With an established base of long-term partnerships with municipal, institutional, commercial and industrial customers, along with a successful acquisition strategy, National Waste has set its course to become a leading waste diversion company.

National Waste's 54-acre landfill facility located in Hernando, Florida, handles annual average disposals of roughly 240,000 cubic yards of construction debris annually. The site also offers an array of ancillary services such as roll-off dumpster services, mulching services and recycling. While the landfill facility is already permitted for future expansion, National Waste's growth strategy also calls for the opening of new satellite offices in counties and states that neighbor its existing operations.

In addition to increasing its geographic foothold, National Waste employs a strategic acquisition model to increase its overall market share. In 2015, the company acquired Gateway Rolloff Services LP and Waste Recovery Enterprises LLC, which are expected to generate a combined $3.8 million in annual revenue for National Waste moving forward. In the second quarter of 2016, National Waste added Sivart Services to its roster, creating an immediate source of additional revenue and expanding its foothold in the northeast area of New York.

Management has confirmed its interest in additional acquisition targets while demonstrating its ability to effectively integrate and organically grow the company's existing acquisition companies and maintain efficient operations. Disclaimer

National Waste Management Holdings, Inc. Company Blog

National Waste Management Holdings, Inc. News:

National Waste Management Holdings Inc. Reports Full-Year 2016 Results, Triple-Digit Revenue Growth

National Waste Management Holdings, Inc. Expands Territory with Acquisition of Burts Refuse, LLC

National Waste Management Holdings, Inc. (NWMH) Expands Market Reach in New York with Acquisition of Northeast Data Destruction and Recycling

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(MARA) +97.14%

2.

Small Cap Firm
(PLLX) +86.05%

3.

QualityStocks
(HPTO) +75.00%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251